Real costs of R& D decoded
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
Rotavirus decreases mortality rate
President and Managing Director, MSD Pharmaceuticals Limited K G Ananthakrishnan and leading paedetrician, Dr Manjira Mitra, announced the national launch of the unique health product in India.
Aurbindo loses stakeholders share
Aurbindo pharma looses 0.91 percent stakes possessed by HSBC Global Investment Funds (Mauritius) Ltd in the open market sales.
New licensing norms soon for Pharma Companies
The industry department is about to finalise the terms under which the government can order the manufacture of drugs without seeking the permission of the patent holder by the end of this month.
Pharma firms demands Data exclusivity
The research-based pharma companies are mounting pressure for stronger regulatory data protection laws.
